Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs

Food Drug Law J. 2008;63(2):459-91.
No abstract available

Publication types

  • Historical Article

MeSH terms

  • Advertising
  • Biological Products / therapeutic use
  • Consumer Product Safety / legislation & jurisprudence*
  • Drug Approval
  • Drug Compounding* / history
  • Drug Industry
  • Drug Prescriptions
  • History, 20th Century
  • Hormone Replacement Therapy
  • Humans
  • Internet
  • Legislation, Drug
  • Menopause / drug effects
  • Organizations
  • Pharmaceutical Services / legislation & jurisprudence*
  • Terminology as Topic
  • Therapeutic Equivalency*
  • United States
  • United States Food and Drug Administration

Substances

  • Biological Products